InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Pizzo Philip A., Director. Insider active across 2 companies, notably Global Blood Therapeutics, Inc.. Aggregated, 6 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €33k. Activity tracked since 21 June 2022. The latest transaction was disclosed on 21 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
9,112 sharesCommon StockSEC:0000899243-22-033158:0
1,260 shares@ US$27.2517100.0% of flowCommon StockSEC:0000899243-22-023598:0
3,600 sharesCommon StockSEC:0000899243-22-022890:0
3,037 sharesCommon StockSEC:0000899243-21-024969
3,037 sharesCommon StockSEC:0000899243-21-024969:0
16,463 sharesCommon StockSEC:0001534424-16-000483:0
6 of 6 declarations
About Pizzo Philip A.
Philip A. Pizzo is a Director at Global Blood Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the healthcare sector and understanding of market challenges allow him to provide valuable insights during board discussions.
